Intestinal Cell News 6.06 February 21, 2020 | |
| |
TOP STORYCell-Type-Specific Signaling Networks in Heterocellular Organoids Simultaneous analysis by mass cytometry of 28 post-translational modifications in >1 million single cells derived from small intestinal organoids revealed cell-type- and cell-state-specific signaling networks in stem, Paneth, enteroendocrine, tuft and goblet cells, as well as enterocytes. [Nat Methods] Abstract | Press Release | |
| |
PUBLICATIONS(Ranked by impact factor of the journal)CRISPR-Based Adenine Editors Correct Nonsense Mutations in a Cystic Fibrosis Organoid Biobank Researchers describe a cystic fibrosis (CF) intestinal organoid biobank, representing 664 patients, of which ~20% could theoretically be repaired by adenine base editing (ABE). They applied SpCas9-ABE and xCas9-ABE on four selected CF organoid samples. [Cell Stem Cell] Abstract | Graphical Abstract Ascl2-Dependent Cell Dedifferentiation Drives Regeneration of Ablated Intestinal Stem Cells By timing the interval between LGR5+ lineage tracing and lethal injury, scientists showed that intestinal stem cell regeneration was explained nearly completely by dedifferentiation, with contributions from absorptive and secretory progenitors. [Cell Stem Cell] Abstract | Graphical Abstract | Press Release Investigators identified one promising miRNA, miR-4711-5p, that downregulated Kruppel-like factor 5 (KLF5) expression by direct binding. This miRNA suppressed cell proliferation, migration and invasion ability, as well as stemness, including decreased stem cell marker expression, reactive oxygen species activity and sphere formation ability. [Br J Cancer] Abstract New Role of the Antidepressant Imipramine as a Fascin1 Inhibitor in Colorectal Cancer Cells Assays investigating lamellipodia formation and migration and invasion of colorectal cancer cells in vitro using 3D human tissue demonstrated anti-fascin1 and anti-invasive activities of imipramine. [Exp Mol Med] Full Article The authors probed the effect of donor microbiota differences, previously identified as a confounding factor in murine in vivo studies, on organoids. They analyzed the proteomes and transcriptomes of primary organoid cultures established from two colonized and one germ‐free mouse colony of C57BL/6J genetic background, and compared them to their tissue of origin and commonly used cell lines. [Cell Microbiol] Abstract APC Controls Wnt-Induced β-Catenin Destruction Complex Recruitment in Human Colonocytes Researchers utilized Wnt3a-beads to locally activate Wnt co-receptors. In response, the endogenous β-catenin destruction complex reoriented toward the local Wnt cue in colorectal cancer cells with full-length Adenomatous Polyposis Coli (APC), but not if APC was truncated or depleted. [Sci Rep] Full Article Using confocal laser scanning microscopy, the authors report that uptake and internalization of CFSE-labeled B. subtilis EVs by Caco-2 cells were time-dependent. [Sci Rep] Full Article Matrine (MAT) prohibited cell viability, accelerated apoptosis, and triggered cells cycle stagnation at the G0/G1 phase. Additionally, miR‐22 was elevated by MAT; meanwhile, the influences of MAT were all inverted by miR‐22 inhibitor. [Phytother Res] Abstract Subscribe to one of our other 19 science newsletters such as Pulmonary Cell News & ESC & iPSC News. | |
| |
REVIEWSThe authors highlight the crosstalk among colon cancer-derived exosomes, macrophage phenotypes and fibroblasts during colon cancer metastasis. [Int Immunopharmacol] Abstract Visit our reviews page to see a complete list of reviews in the intestinal cell research field. | |
| |
INDUSTRY NEWSCytoDyn, Inc. reported that it has received Institutional Review Board approval to begin its Phase II clinical trial for the treatment of approximately 22 different solid tumor cancers, including melanoma, brain-glioblastoma, throat, lung, stomach, colon carcinoma, breast, testicular, ovarian, uterine, pancreas, bladder, among other indications. [CytoDyn, Inc.] Press Release Innovation Pharmaceuticals, Inc. announced that preliminary top-line data from its Phase I trial studying the use of delayed-release tablets of Brilacidin showed the trial met its primary endpoints. [Innovation Pharmaceuticals, Inc.] Press Release | |
| |
POLICY NEWSHas the UK Science Minister Been Demoted? A government reshuffle in the United Kingdom has born another new science minister – a position that has seen a revolving door of appointees, firings and resignations in recent years. The latest appointment also comes with an apparent political demotion for the role, which expert observers say is in conflict with a government that appears to have put research and innovation at the heart of its agenda. [Nature News] Editorial NIH Hosts Nonhuman Primate Workshop Amidst Increased Scrutiny of Monkey Research More than three years after it hosted a workshop on the science and ethics of biomedical studies on monkeys, the National Institutes of Health (NIH) this week convened another workshop on nonhuman primate research. And much like the previous event, the meeting is drawing sharply divergent reactions from biomedical and animal advocacy groups. [ScienceInsider] Editorial Animal Welfare Records Return to USDA Website On February 18, the US Department of Agriculture replaced on its website the animal welfare records that the agency had removed in early 2017 and added records that had been generated since, as ordered by Congress, The Washington Post reports. These documents, unredacted and searchable, include thousands of reports from unannounced inspections at research labs as well as zoos, circuses, dog breeders, and other facilities. [The Scientist] Editorial White House Formally Invites Public Comment on Open-Access Policies The White House issued a notice seeking comment on its effort to enhance public access to federally funded research. It’s an old idea creating new controversy. White House Office of Science and Technology Policy Director Kelvin Droegemeier is pushing back against publishers that in December said the administration was quietly pursuing an executive order to require immediate free distribution of taxpayer funded research. [ScienceInsider] Editorial
| |
EVENTSNEW Tissue Stem Cell Regulation by Autonomous and Non-Autonomous Mechanisms Visit our events page to see a complete list of events in the community.
| |
JOB OPPORTUNITIESNEW Postdoctoral Fellow Position – Gene Editing and Genomic Evolution (Northwestern University) NEW Postdoctoral Position – Intestinal Microbiology and Ecology (Technical University of Denmark) Postdoctoral Position – Inflammatory Bowel Disease (University of Copenhagen) Postdoctoral Fellow – Immunology (Icahn School of Medicine at Mount Sinai) Postdoctoral Position – Intestinal Immunity (The University of Chicago) Postdoctoral Associate – Intestinal Immunology (The Scripps Research Institute) Research Scientist – In Vivo Research on Wnt Signaling in Self-Renewal (Surrozen) Principal Researcher – Systems Disease Biology (Boehringer Ingelheim) Recruit Top Talent: Reach potential candidates by posting your organization’s career opportunities on the Connexon Creative Job Board at no cost.
| |
Have we missed an important article or publication in Intestinal Cell News? Click here to submit! Comments or suggestions? Submit your feedback here. | |
|